Association of Noninvasive Rejection Biomarkers with 10-year Kidney Allograft Survival
In this multicenter, prospective analysis of GEP and dd-cfDNA on patient and graft outcomes, an independent association with long-term ACGL was demonstrated. Further, a time-varying analysis demonstrated that two biomarkers with independent methodologies tested at the same time can provide more information than either one alone.
Authors
- Mulugeta Gebregziabher (ORCID: https://orcid.org/0000-0002-4826-481X)
- Christopher L. Marsh (ORCID: https://orcid.org/0000-0002-6517-076X)
- James N. Fleming (ORCID: https://orcid.org/0000-0001-9686-3107)
- Raymond L. Heilman (ORCID: https://orcid.org/0000-0003-0367-2008)
- Sunil Thuruthummal Kurian
- John J Friedewald
- Steve Kleiboeker
- Lihui Zhao
- Emilio Poggio
- David Taber
Institutions
- Northwestern University (US)
- Cleveland Clinic (US)
- Medical University of South Carolina (US)
- Mayo Clinic Hospital (US)
- Scripps Clinic (US)
- Eurofins (France) (FR)
Publication Details
- Journal
- Kidney360
- Published
- 2026-03-03
- DOI
- https://doi.org/10.34067/kid.0000001167
- Primary Topic
- Renal Transplantation Outcomes and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00